The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Alkaline phosphatase (ALP) normalization and overall survival in patients with bone metastases from castration-resistant prostate cancer (CRPC) treated with radium-223.
Chris Parker
No relevant relationships to disclose
C. Gillies O'Bryan-Tear
No relevant relationships to disclose
Bjørg Bolstad
No relevant relationships to disclose
Anita Lokna
No relevant relationships to disclose
Sten Nilsson
No relevant relationships to disclose